| Katie Lou Matteuzzi, DO | |
|
1100 Wilford Hall Loop, Jbsa Lackland, TX 78236-5638 | |
| (210) 292-7331 | |
| Not Available |
| Full Name | Katie Lou Matteuzzi |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 1100 Wilford Hall Loop, Jbsa Lackland, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063971075 | NPI | - | NPPES |
| Entity Name | Floridian Emergency Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710210695 PECOS PAC ID: 3375682891 Enrollment ID: O20091123000274 |
News Archive
When we acquire diarrhea on a vacation, it is often caused by a bacterial infection. Now a Danish research team is working on a new type of vaccine design targeting the disease causing bacterium - if it works it may very well revolutionize not only the prevention of this disease, but also offer protection against other pathogens with a heavy disease burden such as Mycobacterium tuberculosis and antibiotic-resistant Staphylococcus aureus (MRSA).
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in addition to extensive generic erosion, the hypertension drug market will be constrained through 2018 by a pipeline containing very few emerging therapies with novel mechanisms of action. Gilead's darusentan was positioned to be the next emerging therapy with a novel mechanism of action to reach the hypertension market. However, following darusentan's failure to meet its primary endpoint in the recent DORADO-AC Phase III clinical trial, further development of the agent has been terminated.
Even as the GOP flexes its new political muscle, news outlets offer analysis of the difficulties involved in the long-term strategy to prevent the health law's implementation — including the difficulties involved in attempts to defund it. Meanwhile, PBS explores how this debate could trigger the return of the "death panel" issue.
Life is almost unbearably complex. Humans and mice, frogs and flies toggle genes on and off in dizzying combinations and sequences during their relentless march from embryo to death. Now scientists seeking to understand the machinations of the proteins behind the genomic wizard's screen have a powerful new tool at their disposal, courtesy of researchers at the Stanford University School of Medicine.
An aging population poses challenges for governments around the globe as nations grapple with how to satisfy the physical, social and economic needs of older adults.
› Verified 7 days ago
| Entity Name | Cep America Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295442614 PECOS PAC ID: 6608056171 Enrollment ID: O20230131002198 |
News Archive
When we acquire diarrhea on a vacation, it is often caused by a bacterial infection. Now a Danish research team is working on a new type of vaccine design targeting the disease causing bacterium - if it works it may very well revolutionize not only the prevention of this disease, but also offer protection against other pathogens with a heavy disease burden such as Mycobacterium tuberculosis and antibiotic-resistant Staphylococcus aureus (MRSA).
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in addition to extensive generic erosion, the hypertension drug market will be constrained through 2018 by a pipeline containing very few emerging therapies with novel mechanisms of action. Gilead's darusentan was positioned to be the next emerging therapy with a novel mechanism of action to reach the hypertension market. However, following darusentan's failure to meet its primary endpoint in the recent DORADO-AC Phase III clinical trial, further development of the agent has been terminated.
Even as the GOP flexes its new political muscle, news outlets offer analysis of the difficulties involved in the long-term strategy to prevent the health law's implementation — including the difficulties involved in attempts to defund it. Meanwhile, PBS explores how this debate could trigger the return of the "death panel" issue.
Life is almost unbearably complex. Humans and mice, frogs and flies toggle genes on and off in dizzying combinations and sequences during their relentless march from embryo to death. Now scientists seeking to understand the machinations of the proteins behind the genomic wizard's screen have a powerful new tool at their disposal, courtesy of researchers at the Stanford University School of Medicine.
An aging population poses challenges for governments around the globe as nations grapple with how to satisfy the physical, social and economic needs of older adults.
› Verified 7 days ago
| Entity Name | Emergency Medicine Services Of Fl Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043917180 PECOS PAC ID: 8426413931 Enrollment ID: O20230504001881 |
News Archive
When we acquire diarrhea on a vacation, it is often caused by a bacterial infection. Now a Danish research team is working on a new type of vaccine design targeting the disease causing bacterium - if it works it may very well revolutionize not only the prevention of this disease, but also offer protection against other pathogens with a heavy disease burden such as Mycobacterium tuberculosis and antibiotic-resistant Staphylococcus aureus (MRSA).
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in addition to extensive generic erosion, the hypertension drug market will be constrained through 2018 by a pipeline containing very few emerging therapies with novel mechanisms of action. Gilead's darusentan was positioned to be the next emerging therapy with a novel mechanism of action to reach the hypertension market. However, following darusentan's failure to meet its primary endpoint in the recent DORADO-AC Phase III clinical trial, further development of the agent has been terminated.
Even as the GOP flexes its new political muscle, news outlets offer analysis of the difficulties involved in the long-term strategy to prevent the health law's implementation — including the difficulties involved in attempts to defund it. Meanwhile, PBS explores how this debate could trigger the return of the "death panel" issue.
Life is almost unbearably complex. Humans and mice, frogs and flies toggle genes on and off in dizzying combinations and sequences during their relentless march from embryo to death. Now scientists seeking to understand the machinations of the proteins behind the genomic wizard's screen have a powerful new tool at their disposal, courtesy of researchers at the Stanford University School of Medicine.
An aging population poses challenges for governments around the globe as nations grapple with how to satisfy the physical, social and economic needs of older adults.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Katie Lou Matteuzzi, DO 1100 Wilfod Hall Loop, Jbsa Lackland Afb, TX 78236-9999 Ph: (508) 883-8227 | Katie Lou Matteuzzi, DO 1100 Wilford Hall Loop, Jbsa Lackland, TX 78236-5638 Ph: (210) 292-7331 |
News Archive
When we acquire diarrhea on a vacation, it is often caused by a bacterial infection. Now a Danish research team is working on a new type of vaccine design targeting the disease causing bacterium - if it works it may very well revolutionize not only the prevention of this disease, but also offer protection against other pathogens with a heavy disease burden such as Mycobacterium tuberculosis and antibiotic-resistant Staphylococcus aureus (MRSA).
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in addition to extensive generic erosion, the hypertension drug market will be constrained through 2018 by a pipeline containing very few emerging therapies with novel mechanisms of action. Gilead's darusentan was positioned to be the next emerging therapy with a novel mechanism of action to reach the hypertension market. However, following darusentan's failure to meet its primary endpoint in the recent DORADO-AC Phase III clinical trial, further development of the agent has been terminated.
Even as the GOP flexes its new political muscle, news outlets offer analysis of the difficulties involved in the long-term strategy to prevent the health law's implementation — including the difficulties involved in attempts to defund it. Meanwhile, PBS explores how this debate could trigger the return of the "death panel" issue.
Life is almost unbearably complex. Humans and mice, frogs and flies toggle genes on and off in dizzying combinations and sequences during their relentless march from embryo to death. Now scientists seeking to understand the machinations of the proteins behind the genomic wizard's screen have a powerful new tool at their disposal, courtesy of researchers at the Stanford University School of Medicine.
An aging population poses challenges for governments around the globe as nations grapple with how to satisfy the physical, social and economic needs of older adults.
› Verified 7 days ago
Daniel Allan Weidner, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1100 Wilford Hall Loop, Jbsa Lackland, TX 78236 Phone: 210-292-3403 | |
Dr. Anthony L Mitchell, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1100 Wilford Hall Loop, Jbsa Lackland, TX 78236 Phone: 210-292-3442 | |
Dr. Christopher John Yutzy, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1100 Wilford Hall Loop, Jbsa Lackland, TX 78236 Phone: 210-292-7753 | |
Shannon Nicole Thompson, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1100 Wilford Hall Loop, Jbsa Lackland, TX 78236 Phone: 210-292-7331 | |
Peter John Cuenca, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1100 Wilford Hall Loop Bldg 4554, Jbsa Lackland, TX 78236 Phone: 210-292-7331 | |
Trisha Marion Arno, D.O Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 Wilford Hall Loop Bldg 4554, Jbsa Lackland, TX 78236 Phone: 210-292-0055 |